Which Stem Cell Treatments Are Approved in India?
Stem cell therapy is becoming an increasingly discussed treatment option for various medical conditions. India has also made significant progress in stem cell research, transplantation, and cell-based therapies. However, not every treatment advertised as “stem cell therapy” is an approved treatment in India.
Patients often come across terms such as stem cell treatment, investigational cell therapy, clinical trials, and regenerative medicine, which can make it difficult to understand what is actually approved and what is still under research.
The National Guidelines for Stem Cell Research and the regulatory framework of the Central Drugs Standard Control Organisation (CDSCO) provide guidelines for the development and use of stem cells and cell-based products in India. CDSCO currently regulates areas including clinical-trial approval and marketing authorisation for stem cells and cell-based products.
This blog will provide a clear picture of approved stem cell treatments in India, the difference between established treatment and investigational cell therapy, and what patients should know before considering stem cell treatment.
What Stem Cell Treatments are Approved in India?
One of the most established uses of stem cells in clinical medicine is hematopoietic stem cell transplantation (HSCT). This treatment uses blood-forming stem cells to restore the body’s blood and immune system and is used for several cancers and blood-related disorders.
The National Guidelines for Stem Cell Research include approved indications for HSCT in adults and children. Some of the conditions include:
- Acute Myeloid Leukemia (AML): HSCT may be used in selected patients depending on disease risk and treatment response.
- Acute Lymphoblastic Leukemia (ALL): Stem cell transplantation can be considered in selected high-risk or relapsed cases.
- Myelodysplastic Syndromes (MDS): HSCT is an established treatment option for eligible patients.
- Multiple Myeloma: Autologous stem cell transplantation is commonly used as part of treatment for selected patients.
- Hodgkin and Non-Hodgkin Lymphomas: HSCT can be used in certain relapsed or high-risk cases.
- Aplastic Anaemia: Stem cell transplantation can be used to restore bone marrow function in appropriate patients.
- Inherited Blood Disorders: Certain conditions, including selected cases of sickle cell disease and inherited immune or blood disorders, may be treated with HSCT.
The suitability of transplantation depends on factors such as the patient’s age, disease status, overall health, donor availability, and previous treatment.
What is Hematopoietic Stem Cell Transplantation?
Hematopoietic stem cells are blood-forming stem cells that can develop into different types of blood cells.
In HSCT, these cells may be collected from the patient or from a suitable donor. After the patient’s existing bone marrow has been treated as required, the stem cells are infused to help rebuild the blood-forming and immune systems.
There are two main types of HSCT:
- Autologous Stem Cell Transplant: Stem cells are collected from the patient’s own body and later returned to the patient.
- Allogeneic Stem Cell Transplant: Stem cells are obtained from a suitable donor.
The choice between these approaches depends on the disease and the patient’s individual medical condition.
Which Conditions Can Be Treated With Hematopoietic Stem Cells?
This is one of the most important questions patients should understand.
Stem cell research is being conducted for many conditions, including arthritis, spinal cord injuries, diabetes, stroke, Parkinson’s disease and other neurological disorders. However, research into a treatment does not automatically mean that the treatment is an approved standard therapy.
Patients should therefore be cautious about claims that a stem cell injection can “cure” a particular condition.
The regulatory status depends on the specific cell product, manufacturing process, indication, clinical evidence and regulatory approvals.
For example, a stem cell treatment being investigated in a clinical trial for knee arthritis should not be described as an established treatment simply because stem cells are already used for certain blood disorders.
What is Investigational Cell Therapy?
An investigational cell therapy is a treatment that is still being evaluated to determine its safety, effectiveness and appropriate use.
Such therapies may be studied through clinical trials before they can become established treatments.
CDSCO’s regulatory framework covers stem cells and cell-based products and includes processes for clinical-trial approval and marketing authorisation. CDSCO also maintains information on clinical-trial permissions for cell and gene therapeutic products.
Therefore, patients should understand the difference between:
- An established treatment: A treatment with an accepted clinical use.
- A clinical trial: A structured research study conducted to evaluate a treatment.
- An investigational therapy: A treatment that is still being evaluated.
- An advertised procedure: A treatment being promoted by a provider, which does not by itself establish regulatory approval.
How are Stem Cell Clinical Trials Regulated in India?
India has a regulatory framework for clinical research involving stem cells and cell-based products.
Some of the important regulatory bodies and requirements include:
- CDSCO: Responsible for regulatory functions related to drugs and biological products, including clinical-trial approvals and marketing authorisation for stem cells and cell-based products.
- ICMR: Provides national guidance for ethical and scientific conduct of stem cell research.
- Institutional Committees: Research involving stem cells may require appropriate institutional scientific and ethical review.
- Clinical Trial Registration: Clinical trials in India are registered through the Clinical Trials Registry–India (CTRI) as applicable.
The National Guidelines for Stem Cell Research provide a framework covering research, clinical trials, ethical considerations and the use of stem cells in India.
What is the Difference Between an Approved Treatment and a Clinical Trial?
Patients should understand this difference before choosing stem cell therapy.
Approved or Established Treatment | Investigational Cell Therapy |
Has an established clinical use | Still being evaluated |
Supported by clinical evidence | Evidence may still be developing |
Used within accepted medical practice | Generally studied through clinical research |
Safety and effectiveness are better established | Safety and effectiveness may still be uncertain |
Treatment is provided for recognised indications | Treatment is provided under an approved research protocol |
A treatment being offered inside a hospital does not automatically mean that it is an approved treatment for every condition.
What Should Patients Check Before Choosing Stem Cell Therapy?
Patients considering stem cell treatment in India should collect as much information as possible before proceeding.
Some of the important questions to ask are:
- What type of stem cells are being used?
- Where are the cells obtained from?
- Is the treatment approved for my specific condition?
- Is the procedure part of a registered clinical trial?
- What scientific evidence supports the treatment?
- What are the possible risks and side effects?
- Which regulatory approvals are applicable to the treatment?
- Are there other established treatment options available?
These questions can help patients distinguish between a recognised medical treatment and a therapy that is still under investigation.
Why is Stem Cell Regulation Important in India?
Stem cells are biological products, and their use can involve complex issues related to cell collection, processing, storage, manufacturing, quality control, safety and clinical use.
CDSCO specifically lists Stem Cells and Cell Based Products under its biological-products functions. Its responsibilities include clinical-trial approval and marketing authorisation, along with other regulatory permissions.
The regulatory framework is important because it helps ensure that new cell-based therapies are evaluated for their quality, safety and effectiveness before they are widely used.
Are All Stem Cell Treatments Available in India Approved?
No.
This is one of the most important points for patients researching stem cell therapy.
A treatment may be:
- An established clinical treatment.
- Under clinical investigation.
- Part of a clinical trial.
- Available through a research programme.
- Advertised by a healthcare provider.
These categories should not be considered interchangeable.
Patients should particularly avoid assuming that a treatment is approved simply because it is being offered commercially or because a clinic describes it as “advanced stem cell therapy.”
What Does the Future of Stem Cell Therapy Look Like in India?
India continues to develop its capabilities in cell and gene therapies, stem cell research and regenerative medicine.
CDSCO’s current stem-cell and cell-based-products framework includes provisions for clinical trials and regulatory permissions. The organisation also publishes information on clinical-trial permissions and manufacturing permissions for cell and gene therapeutic products.
As research progresses, some investigational therapies may eventually develop into established treatments. However, this requires evidence from properly conducted clinical research and appropriate regulatory evaluation.
In Conclusion
Stem cell therapy has significant potential in modern medicine, but not every stem cell treatment available in India is an approved treatment.
Hematopoietic stem cell transplantation is an established medical treatment with recognised indications across several blood cancers, blood disorders and selected other conditions. At the same time, many newer applications of stem cells are still being studied through clinical research.
Therefore, patients should always check the specific indication, type of stem cells, clinical evidence, regulatory status and clinical-trial status before choosing a stem cell treatment.
Understanding the difference between approved stem cell treatments in India and investigational cell therapy can help patients and caregivers make more informed healthcare decisions.
Disclaimer: This blog is for educational purposes only and should not be considered medical advice. The regulatory status of specific cell-based products and treatments may change. Patients should consult a qualified medical specialist and verify the current regulatory status before proceeding with any treatment.